General Surgery Considerations in the Era of Mechanical Circulatory Assist Devices

Limael E. Rodriguez, Erik E. Suarez, Matthias Loebe, Brian A. Bruckner

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Much of the success of left ventricular assist devices (LVAD) can be attributed to the second-generation HeartMate II (Thoratec, Pleasanton, CA, USA), which is the most commonly used device to date. The latest generation of LVADs is currently undergoing clinical trials worldwide. Developers have focused on improving the limitations of the second generation with emphasis on enhancing efficiency further, decreasing complications, and increasing ease of implantability. Clinical management of a patient with an LVAD is also an excellent example of the multidisciplinary approach of care that is undoubtedly the future of medicine.

Original languageEnglish (US)
Pages (from-to)1343-1357
Number of pages15
JournalSurgical Clinics of North America
Volume93
Issue number6
DOIs
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Heart-Assist Devices
Equipment and Supplies
Medicine
Clinical Trials

Keywords

  • General surgery
  • Left ventricular assist device
  • LVAD
  • Mechanical circulatory support
  • Noncardiac surgery

ASJC Scopus subject areas

  • Surgery

Cite this

General Surgery Considerations in the Era of Mechanical Circulatory Assist Devices. / Rodriguez, Limael E.; Suarez, Erik E.; Loebe, Matthias; Bruckner, Brian A.

In: Surgical Clinics of North America, Vol. 93, No. 6, 12.2013, p. 1343-1357.

Research output: Contribution to journalArticle

Rodriguez, Limael E. ; Suarez, Erik E. ; Loebe, Matthias ; Bruckner, Brian A. / General Surgery Considerations in the Era of Mechanical Circulatory Assist Devices. In: Surgical Clinics of North America. 2013 ; Vol. 93, No. 6. pp. 1343-1357.
@article{11e8a813846841adbcfb0ca4ed58db39,
title = "General Surgery Considerations in the Era of Mechanical Circulatory Assist Devices",
abstract = "Much of the success of left ventricular assist devices (LVAD) can be attributed to the second-generation HeartMate II (Thoratec, Pleasanton, CA, USA), which is the most commonly used device to date. The latest generation of LVADs is currently undergoing clinical trials worldwide. Developers have focused on improving the limitations of the second generation with emphasis on enhancing efficiency further, decreasing complications, and increasing ease of implantability. Clinical management of a patient with an LVAD is also an excellent example of the multidisciplinary approach of care that is undoubtedly the future of medicine.",
keywords = "General surgery, Left ventricular assist device, LVAD, Mechanical circulatory support, Noncardiac surgery",
author = "Rodriguez, {Limael E.} and Suarez, {Erik E.} and Matthias Loebe and Bruckner, {Brian A.}",
year = "2013",
month = "12",
doi = "10.1016/j.suc.2013.08.004",
language = "English (US)",
volume = "93",
pages = "1343--1357",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - General Surgery Considerations in the Era of Mechanical Circulatory Assist Devices

AU - Rodriguez, Limael E.

AU - Suarez, Erik E.

AU - Loebe, Matthias

AU - Bruckner, Brian A.

PY - 2013/12

Y1 - 2013/12

N2 - Much of the success of left ventricular assist devices (LVAD) can be attributed to the second-generation HeartMate II (Thoratec, Pleasanton, CA, USA), which is the most commonly used device to date. The latest generation of LVADs is currently undergoing clinical trials worldwide. Developers have focused on improving the limitations of the second generation with emphasis on enhancing efficiency further, decreasing complications, and increasing ease of implantability. Clinical management of a patient with an LVAD is also an excellent example of the multidisciplinary approach of care that is undoubtedly the future of medicine.

AB - Much of the success of left ventricular assist devices (LVAD) can be attributed to the second-generation HeartMate II (Thoratec, Pleasanton, CA, USA), which is the most commonly used device to date. The latest generation of LVADs is currently undergoing clinical trials worldwide. Developers have focused on improving the limitations of the second generation with emphasis on enhancing efficiency further, decreasing complications, and increasing ease of implantability. Clinical management of a patient with an LVAD is also an excellent example of the multidisciplinary approach of care that is undoubtedly the future of medicine.

KW - General surgery

KW - Left ventricular assist device

KW - LVAD

KW - Mechanical circulatory support

KW - Noncardiac surgery

UR - http://www.scopus.com/inward/record.url?scp=84887258704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887258704&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2013.08.004

DO - 10.1016/j.suc.2013.08.004

M3 - Article

VL - 93

SP - 1343

EP - 1357

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 6

ER -